Articles les plus consultés
-
francis 13 Version sans publicité Marchés Actualités Analyses Crypto Fonds Graphiques Technique Brokers Outils Portefe...
-
6% Hydroxyethyl Starch 130 / 0.4 in 0.9% Injection de chlorure de sodium (Voluven 500 mL freeflex flexible en plastique intraveineuse solut...
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Iridium 14.95 + 39.07% 0,60K Mondialisation de l'Inde. 0,4800 + 18,52% 1,80K...
-
Top Gaining Stocks % Chg Dernier Symb Compagnie Le volume 16,22% 2.15 SRNE Sorrento Therapeut 7030 10,92% 2,64 CIE Cobalt Inte...
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Oracle Corporation 51.30 + 10,73% 58.90K Staples Inc 9.25 + 6,81% 12,31K Delcat...
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Delcath 0.1230 + 24,24% 196,67K Neos Therapeutics I. 10.50 +16.67% 34.36K Enpha...
-
Citoyens_Français @citoyenneFrance 8 juin Plus Attali : « Les élus n’ont plus de pouvoir et voici votre avenir » - Effr......
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Lipocine In 5.32 + 32,34% 38.64K Enphase Energy Inc 0,938 + 17,57% 10,37K Delca...
-
28 juin 2017 Nom du médicament et numéro de demande Ingrédient actif Formulaire de posologie / itinéraire Soumission Compagnie ...
-
Plus fortes hausses en préouverture Nom Dernier Var.% Vol. DragonWave Inc 1,3900 +25,23% 3,55K Alibaba 139,95 +11,35% 1,40M MoSys...
mercredi 4 avril 2018
Poxel Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference | Business Wire
Poxel Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference | Business Wire: POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic diseases, in
RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment
RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment: World’s Only Biology-Guided Radiation Therapy Could Help Millions More Patients Worldwide
mardi 3 avril 2018
HGS Acquires AxisPoint Health | Business Wire
HGS Acquires AxisPoint Health | Business Wire: Hinduja Global Solutions Limited (HGS) (Listed on NSE & BSE, India), has announced that its subsidiary, HGS Population Health LLC, USA, has acquir
GenSight Biologics announces topline results from REVERSE Phase III clinical trial of GS010 in patients with Leber Hereditary Optic Neuropathy (LHON) | Business Wire
GenSight Biologics announces topline results from REVERSE Phase III clinical trial of GS010 in patients with Leber Hereditary Optic Neuropathy (LHON) | Business Wire: Regulatory News: GenSight Biologics (Paris: SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering
ProBiora Health Partners with The Jackson Galaxy Project to Support Oral Health in Sheltered Dogs and Cats | Business Wire
ProBiora Health Partners with The Jackson Galaxy Project to Support Oral Health in Sheltered Dogs and Cats | Business Wire: In partnership with The Jackson Galaxy Project, an acclaimed animal welfare program of GreaterGood.org, ProBiora Health has donated more than 3,000 un
Neurocentrx nomme deux poids lourds de l'industrie de son conseil d'administration
Neurocentrx nomme deux poids lourds de l'industrie de son conseil d'administration: Neurocentrx, an Edinburgh-based pharmaceutical company, has appointed Nigel Brooksby as non-executive chairman and Dr Tim Corn as non-executive Director to take the company to a global market.
Axonics® Announces $40 Million Financing | Business Wire
Axonics® Announces $40 Million Financing | Business Wire: Axonics Modulation Technologies, Inc., a privately-held developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment o
Inscription à :
Articles (Atom)